Parkinsonism during cyclosporine treatment

Bone Marrow Transplantation

Volumn 18, Issue 3, 1996, Pages 649-650

  Wasserstein, P H ^a   Honig, L S ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Bone marrow transplantation; Drug induced parkinsonism; Tremor

Indexed keywords

CARBIDOPA PLUS LEVODOPA; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BRADYKINESIA; BRAIN DISEASE; CASE REPORT; CEREBRAL BLINDNESS; DRUG EFFICACY; FEMALE; HEADACHE; HUMAN; MALE; PARKINSONISM; PRIORITY JOURNAL; SEIZURE; TREMOR; VISUAL HALLUCINATION;

ADULT; BONE MARROW TRANSPLANTATION; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; PARKINSON DISEASE, SECONDARY;

EID: 0029816196     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Faulds D, Goa KL, Benfield P. Cyclosporin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 1993; 45: 953-1040.
2. Atkinson K. Cyclosporin in bone marrow transplantation. Bone Marrow Transplant 1987; 1: 265-270.
3. Walker RW, Brochstein JA. Neurologic complications of immunosuppressive agents. Neurol Clin 1988; 6: 261-278.
4. Reece DE, Frei LD, Shepherd JD et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991; 8: 393-401.
5. Kahan BD, Flechner SM, Lorber MI et al. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years. Transplantation 1987; 43: 197-204.
6. European Multicentre Trial Group. Cyclosporin in cadaveric renal transplantation: one year follow-up of a multicentre trial. Lancet 1983; 2: 986-989.
7. de Groen PC, Aksamit AJ, Rakela J et al. Central nervous system toxicity after liver transplantation: the role of cyclosporine and cholesterol. New Engl J Med 1987; 317: 861-866.
8. Lucey MR, Kolars JC, Merion RM et al. Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA. Lancet 1990; 335: 11-15.
9. Wasserstein PH, Honig LS. A novel tremor in patients treated with cyclosporine. Neurology 1994; 44 (Suppl. 2): A213 (Abstr.).
10. Boland J, Atkinson K, Britton K et al. Tissue distribution and toxicity of cyclosporin A in the mouse. Pathology 1984; 16: 117-123.